For: |
Liu BH, Mo P, Zhang SB. Effects of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i11/1672.htm |
Number | Citing Articles |
1 |
Yang-Yang Meng, Qiao-Dong Li, Ya Feng, Jie Liu, En-Kang Wang, Linda Zhong, Qiao-Li Sun, Jian-Ye Yuan. Animal models of cathartic colon. World Journal of Clinical Cases 2021; 9(6): 1251-1258 doi: 10.12998/wjcc.v9.i6.1251
|
2 |
Richard J. Bodnar, Gad E. Klein. Endogenous opiates and behavior: 2004. Peptides 2005; 26(12): 2629 doi: 10.1016/j.peptides.2005.06.010
|
3 |
S. A. Bulgakov. The use of agonists of opioid peptide receptors in the gastroenterological practice. Dokazatel'naya gastroenterologiya 2015; 4(1): 14 doi: 10.17116/dokgastro201541-214-18
|
4 |
Marco Marzioni, Gianfranco Alpini, Stefania Saccomanno, Samuele de Minicis, Shannon Glaser, Heather Francis, Luciano Trozzi, Juliet Venter, Fiorenza Orlando, Giammarco Fava, Cinzia Candelaresi, Giampiero Macarri, Antonio Benedetti. Endogenous Opioids Modulate the Growth of the Biliary Tree in the Course of Cholestasis. Gastroenterology 2006; 130(6): 1831 doi: 10.1053/j.gastro.2006.02.021
|
5 |
JINSONG WU, BAOHUA LIU, WEIDONG TONG, ANPING ZHANG, FAN LI, JING LIN, LI WANG. Opioid receptors and associated regulator of G protein signaling are involved in the cathartic colon of rats. Experimental and Therapeutic Medicine 2015; 9(4): 1229 doi: 10.3892/etm.2015.2233
|
6 |
M. A. Medvedev, I. V. Rudin, A. F. Garaeva. Role of hepatic opioid receptors in the regulation of bile excretion. Bulletin of Experimental Biology and Medicine 2006; 142(5): 551 doi: 10.1007/s10517-006-0415-6
|
7 |
Marta Zielińska, Agata Jarmuż, Andrzej Wasilewski, Gerta Cami-Kobeci, Stephen Husbands, Jakub Fichna. Methyl-orvinol—Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome. Pharmacological Reports 2017; 69(2): 350 doi: 10.1016/j.pharep.2016.12.001
|
8 |
Recommandations pour la prévention et le traitement de la constipation induite par les opioïdes chez le patient relevant de soins palliatifs. Médecine Palliative : Soins de Support - Accompagnement - Éthique 2009; 8: S5 doi: 10.1016/S1636-6522(09)70064-9
|